Liver fibrosis is a hallmark of chronic liver disease (CLD) characterized by the excessive accumulation of extracellular matrix proteins. To diagnose and grade the liver fibrosis, liver biopsy is the reference standard, however the method has some limitations, including potential pain, sampling variability, and low patient acceptance. Therefore, there have been efforts to develop noninvasive imaging techniques and quantification softwares for diagnosis, staging, and monitoring of liver fibrosis. This study developed a MRI-suitable quantification program for assessing heterogeneity and nodularity in the liver and compared the difference between fibrosis grades in CLD.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords